BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and Andes orthohantavirus

Background:Mycobacterium bovis Bacillus Calmette-Guérin (BCG) is a live attenuated vaccine mainly administered to newborns and used for over 100 years to prevent the disease caused by Mycobacterium tuberculosis (M. tb). This vaccine can induce immune response polarization towards a Th1 profile, whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Soto, Jorge A., Díaz, Fabián E., Retamal-Díaz, Angello, Gálvez, Nicolás M. S., Melo-González, Felipe, Piña-Iturbe, Alejandro, Ramírez, Mario A., Bohmwald, Karen, González, Pablo A., Bueno, Susan M., Kalergis, Alexis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143576/
https://www.ncbi.nlm.nih.gov/pubmed/35632475
http://dx.doi.org/10.3390/vaccines10050721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143576/
https://www.ncbi.nlm.nih.gov/pubmed/35632475
http://dx.doi.org/10.3390/vaccines10050721

Ejemplares similares